Antiretroviral therapy adherence strategies used by patients of a large HIV clinic in Lesotho

Journal of Health, Population and Nutrition

Volumn 33, Issue 1, 2015, Pages

  Axelsson, Johanna Maria ^a   Hallager, Sofie ^b   Barfod, Toke S ^c  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c ROSKILDE HOSPITAL   (Denmark)

Author keywords

Adherence; Antiretroviral therapy; Barriers; Facilitators; HIV AIDS; Lesotho; Sub saharan Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ATTITUDE TO HEALTH; COMBINATION DRUG THERAPY; DAILY LIFE ACTIVITY; DRUG ADMINISTRATION; ETHNOLOGY; FEMALE; GROUNDED THEORY; HIV INFECTIONS; HUMAN; LESOTHO; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MOBILE PHONE; OUTPATIENT DEPARTMENT; PATIENT EDUCATION; PSYCHOLOGICAL MODEL; SELF REPORT; SOCIAL SUPPORT; YOUNG ADULT;

ACTIVITIES OF DAILY LIVING; ADULT; AMBULATORY CARE FACILITIES; ANTI-RETROVIRAL AGENTS; CELL PHONES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GROUNDED THEORY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; LESOTHO; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; PATIENT EDUCATION AS TOPIC; SELF REPORT; SOCIAL SUPPORT; YOUNG ADULT;

EID: 84938491894     PISSN: 16060997     EISSN: 20721315     Source Type: Journal    
DOI: 10.1186/s41043-015-0026-9     Document Type: Article

References (44)

1. Joint United Nations Programme on HIV/AIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. Geneva: UNAIDS; 2013.
2. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181-3.
3. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann. Intern. Med. 2003;139(10):810-6.
4. Nachega JB, Mills EJ, Schechter M. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr. Opin.HIV. AIDS. 2010;5(1):70-7.
5. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003;37(8):1112-8.
6. Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191(3):339-47.
7. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008;13 Suppl 2:1-13.
8. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J AcquirImmune Defic Syndr. 2006;43 Suppl 1:S79-87.
9. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679-90.
10. Duff P, Kipp W, Wild TC, Rubaale T, Okech-Ojony J. Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. J Int AIDS Soc. 2010;13:37.
11. Kip E, Ehlers VJ, van der Wal DM. Patients' adherence to anti-retroviral therapy in Botswana. J Nurs Scholarsh. 2009;41(2):149-57.
12. Murray LK, Semrau K, McCurley E, Thea DM, Scott N, Mwiya M, et al. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care. 2009;21(1):78-86.
13. Dahab M, Charalambous S, Hamilton R, Fielding K, Kielmann K, Churchyard GJ, et al. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008;8:63.
14. Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. SAHARAJ. 2008;5(3):136-43.
15. Byakika-Tusiime J, Crane J, Oyugi JH, Ragland K, Kawuma A, Musoke P, et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009;13 Suppl 1:82-91.
16. Liu H, Miller LG, Hays RD, Golin CE, Wu T, Wenger NS, et al. Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr. 2006;41(3):315-22.
17. Parruti G, Manzoli L, Toro PM, D'Amico G, Rotolo S, Graziani V, et al. Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse. AIDS Patient Care STDS. 2006;20(1):48-56.
18. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2012. Geneva, Switzerland. 2012. http://www.unaids.org/sites/default/files/media_asset/20121120_UNAIDS_Global_Report_2012_with_annexes_en_1http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/document.
19. WHO, UNICEF, UNAIDS. Global update on HIV treatment 2013: Results, impact and opportunities. Geneva, Switzerland. 2013 Jun. http://apps.who.int/iris/bitstream/10665/85326/1/9789241505734_eng.pdf?ua=1.
20. Barfod TS, Sørensen HT, Nielsen H, Rodkjær L, Obel N. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence. HIV Med. 2006;7(5):285-290.
21. Corbin J, Strauss A. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. 3rd ed. Los Angeles: SAGE Publications; 2007.
22. United Nations Development Programme (UNDP). Human Development Report 2013-The Rise of the South: Human Progress in a Diverse World. New York, USA. 2013. http://hdr.undp.org/sites/default/files/reports/14/hdr2013_en_complete.pdf.
23. Ministry of Health and Social Welfare (MOHSW) [Lesotho] and ICF Macro. Lesotho Demographic and Health Survey 2009. Maseru: MOHSW and ICF Macro; 2010.
24. Liang X, Tan J-P, Mutumbuka DB. Primary and secondary education in Lesotho-a Country Status Report for education. Africa Region Human Development working paper series. Washington: World Bank; 2005.
25. Barnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011;11(12):942-51.
26. Barnett W, Patten G, Kerschberger B, Conradie K, Garone DB, van Cutsem G, et al. Perceived adherence barriers among patients failing second-line antiretroviral therapy in Khayelitsha, South Africa. South Afr J HIV Med. 2013;14(2013):166-9.
27. Cohen CJ, Colson AE, Sheble-Hall AG, McLaughlin KA, Morse GD. Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study. HIV.Clin. Trials. 2007;8(1):19-23.
28. Ananworanich J, Nuesch R, Le BM, Chetchotisakd P, Vibhagool A, Wicharuk S, et al. Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS. 2003;17(15):F33-7.
29. Dybul M, Nies-Kraske E, Daucher M, Hertogs K, Hallahan CW, Csako G, et al. Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters. J Infect Dis. 2003;188(3):388-96.
30. Senkomago V, Guwatudde D, Breda M, Khoshnood K. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga. Uganda AIDS Care. 2011;23(10):1246-53.
31. Parienti JJ, Bangsberg DR, Verdon R, Gardner EM. Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis. 2009;48(4):484-8.
32. Nagata JM, Magerenge RO, Young SL, Oguta JO, Weiser SD, Cohen CR. Social determinants, lived experiences, and consequences of household food insecurity among persons living with HIV/AIDS on the shore of Lake Victoria. Kenya AIDS Care. 2012;24(6):728-36.
33. Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One. 2010;5(4):e10340.
34. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658-65.
35. Cantrell RA, Sinkala M, Megazinni K, Lawson-Marriott S, Washington S, Chi BH, et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka. Zambia J Acquir Immune Defic Syndr. 2008;49(2):190-5.
36. Hahn JA, Woolf-King SE, Muyindike W. Adding fuel to the fire: alcohol's effect on the HIV epidemic in Sub-Saharan Africa. CurrHIV/AIDS Rep. 2011;8(3):172-80.
37. Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, Kassie DM. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia. PLoS One. 2014;9(5):e97353.
38. Hardon A. World Health Organization. From access to adherence the challenges of antiretroviral treatment: studies from Botswana, Tanzania and Uganda. Geneva, Switzerland. 2006. 0 AD. http://whqlibdoc.who.int/publications/2006/9241563281_eng.pdf .
39. Horvath T, Azman H, Kennedy GE, Rutherford GW. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev. 2012;3:CD009756.
40. ITU (International Telecommunication Union). Lesotho Profile (Latest data available: 2013). http://www.itu.int/net4/itu-d/icteye/Geneva,Switzerland.
41. Africa's mobile economic revolution Killian Fox, The Guardian. 2011 Jul 24.
42. Vital Wave Consulting. mHealth for Development: The Opportunity of Mobile Technology for Healthcare in the Developing World. Washington, D.C. and Berkshire, UK: UN Foundation-Vodafone Foundation Partnership. Web adress: http://www.globalproblems-globalsolutions-files.org/unf_website/assets/publications/technology/mhealth/mHealth_for_Development_full.pdf.
43. Africa's mobile phone industry 'booming' BBC News Africa. 2011 Nov 9.
44. Gusdal AK, Obua C, Andualem T, Wahlstrom R, Chalker J, Fochsen G. Peer counselors' role in supporting patients' adherence to ART in Ethiopia and Uganda. AIDS Care. 2011;23(6):657-62.